Action 2269 WUXI BIOLOGICS (CAYMAN) INC.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription
Instrument Inactif

Autres langues WuXi Biologics (Cayman) Inc. Hong Kong S.E.

Actions

2269

KYG970081090

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !
Inscription 100% Gratuite
Wuxi Biologics Terms US Plant's Expansion Halt as Normal Business Adjustment
WuXi Biologics Named to MSCI ESG Leaders Indexes for Second Consecutive Year
WuXi Biologics Cayman : Named to MSCI ESG Leaders Indexes for Second Consecutive Year
WuXi Biologics Surges to 19-Month High Wednesday on Hopes of Avoiding US Ban
WuXi Biologics Enhances Manufacturing Capability with the Installation of Three 5,000L Single-Use Bioreactors
WuXi facility boosts bioprocessing capacity with new bioreactors
US lawmakers ask FBI for briefing on GenScript Biotech's links to China
US lawmakers ask FBI for briefing on GenScript Biotech's links to China
China stocks rise as industrial profits grow; energy, semiconductor shares lead gains
Wuxi Biologics (Cayman) Maintains it is Not a Security Threat After House Bill Changes; Stocks Drop 3%
US House committee advances bill to restrict BGI, WuXi AppTec
US House committee to vote on bill to restrict BGI, WuXi AppTec
US Congress Drafts Bill Asking Drug Firms to Unlink from Chinese Biotech Firms
WuXi Shares Volatile as U.S. Bill Revised to Set Deadline for Decoupling
U.S. bill to restrict WuXi AppTec, other Chinese biotech cos revised to give more time to cut ties
Pacific Assets Trust cautiously optimistic after outpacing benchmark
WuXi Biologics Cayman : Releases 2023 ESG Report Demonstrating Strong Sustainability Commitment
WuXi Biologics Selected for S&P Global Sustainability Yearbook 2024
WuXi Biologics Wins 2024 CDMO Leadership Awards in All Categories
Wuxi Biologics Inc. Announces Retirement of Weichang Zhou as Chief Technology Officer and President of Global Biologics Development and Operations and Re-Designates as Non-Executive Director and Honorary President of Global Biologics Development and Operations and Senior Advisor to Chief Executive Officer
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action 2269
  4. Action 2269
  5. Actualités WuXi Biologics (Cayman) Inc.
  6. Autres langues